FDA Inspection 1094159 — Maprimed S.A.
The FDA completed an inspection of Maprimed S.A. on June 7, 2019 in Ciudad Autonoma Buenos Aires. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 7, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ciudad Autonoma Buenos Aires (Argentina)